<unk> , sold under the brand name Fintepla, is a medication used for the treatment of seizures associated with Dravet syndrome in people age two and older. The most common adverse reactions include decreased appetite; drowsiness, sedation and lethargy; diarrhea; constipation; abnormal echocardiogram; fatigue or lack of energy; ataxia (lack of coordination), balance disorder, gait disturbance (trouble with walking); increased blood pressure; drooling, salivary hypersecretion (saliva overproduction); pyrexia (fever); upper respiratory tract infection; vomiting; decreased weight; risk of falls; and status epilepticus.
Fenfluramine
Benzoctamine
Tesofensine
Bremazocine
Dezocine
Clorotepine
Bethanechol
Ephedrine